248 related articles for article (PubMed ID: 23118946)
1. Susceptibility of human head and neck cancer cells to combined inhibition of glutathione and thioredoxin metabolism.
Sobhakumari A; Love-Homan L; Fletcher EV; Martin SM; Parsons AD; Spitz DR; Knudson CM; Simons AL
PLoS One; 2012; 7(10):e48175. PubMed ID: 23118946
[TBL] [Abstract][Full Text] [Related]
2. Targeting redox homeostasis in rhabdomyosarcoma cells: GSH-depleting agents enhance auranofin-induced cell death.
Habermann KJ; Grünewald L; van Wijk S; Fulda S
Cell Death Dis; 2017 Oct; 8(10):e3067. PubMed ID: 28981107
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of glutathione and thioredoxin metabolism enhances sensitivity to perifosine in head and neck cancer cells.
Simons AL; Parsons AD; Foster KA; Orcutt KP; Fath MA; Spitz DR
J Oncol; 2009; 2009():519563. PubMed ID: 19746172
[TBL] [Abstract][Full Text] [Related]
4. Targeting of the Glutathione, Thioredoxin, and Nrf2 Antioxidant Systems in Head and Neck Cancer.
Roh JL; Jang H; Kim EH; Shin D
Antioxid Redox Signal; 2017 Jul; 27(2):106-114. PubMed ID: 27733046
[TBL] [Abstract][Full Text] [Related]
5. Enhancement of Radiation Response in Breast Cancer Stem Cells by Inhibition of Thioredoxin- and Glutathione-Dependent Metabolism.
Rodman SN; Spence JM; Ronnfeldt TJ; Zhu Y; Solst SR; O'Neill RA; Allen BG; Guan X; Spitz DR; Fath MA
Radiat Res; 2016 Oct; 186(4):385-395. PubMed ID: 27643875
[TBL] [Abstract][Full Text] [Related]
6. Simultaneous inhibition of glutathione- and thioredoxin-dependent metabolism is necessary to potentiate 17AAG-induced cancer cell killing via oxidative stress.
Scarbrough PM; Mapuskar KA; Mattson DM; Gius D; Watson WH; Spitz DR
Free Radic Biol Med; 2012 Jan; 52(2):436-43. PubMed ID: 22100505
[TBL] [Abstract][Full Text] [Related]
7. Dual targeting of the thioredoxin and glutathione antioxidant systems in malignant B cells: a novel synergistic therapeutic approach.
Kiebala M; Skalska J; Casulo C; Brookes PS; Peterson DR; Hilchey SP; Dai Y; Grant S; Maggirwar SB; Bernstein SH
Exp Hematol; 2015 Feb; 43(2):89-99. PubMed ID: 25448488
[TBL] [Abstract][Full Text] [Related]
8. Enhancement of carboplatin-mediated lung cancer cell killing by simultaneous disruption of glutathione and thioredoxin metabolism.
Fath MA; Ahmad IM; Smith CJ; Spence J; Spitz DR
Clin Cancer Res; 2011 Oct; 17(19):6206-17. PubMed ID: 21844013
[TBL] [Abstract][Full Text] [Related]
9. 2-Deoxy-D-glucose combined with cisplatin enhances cytotoxicity via metabolic oxidative stress in human head and neck cancer cells.
Simons AL; Ahmad IM; Mattson DM; Dornfeld KJ; Spitz DR
Cancer Res; 2007 Apr; 67(7):3364-70. PubMed ID: 17409446
[TBL] [Abstract][Full Text] [Related]
10. Thioredoxin-1 redox signaling regulates cell survival in response to hyperoxia.
Floen MJ; Forred BJ; Bloom EJ; Vitiello PF
Free Radic Biol Med; 2014 Oct; 75():167-77. PubMed ID: 25106706
[TBL] [Abstract][Full Text] [Related]
11. Disruption of thioredoxin metabolism enhances the toxicity of transforming growth factor β-activated kinase 1 (TAK1) inhibition in KRAS-mutated colon cancer cells.
Hrabe JE; O'Leary BR; Fath MA; Rodman SN; Button AM; Domann FE; Spitz DR; Mezhir JJ
Redox Biol; 2015 Aug; 5():319-327. PubMed ID: 26114584
[TBL] [Abstract][Full Text] [Related]
12. Combined inhibition of glycolysis, the pentose cycle, and thioredoxin metabolism selectively increases cytotoxicity and oxidative stress in human breast and prostate cancer.
Li L; Fath MA; Scarbrough PM; Watson WH; Spitz DR
Redox Biol; 2015; 4():127-35. PubMed ID: 25560241
[TBL] [Abstract][Full Text] [Related]
13. Selective targeting of the cysteine proteome by thioredoxin and glutathione redox systems.
Go YM; Roede JR; Walker DI; Duong DM; Seyfried NT; Orr M; Liang Y; Pennell KD; Jones DP
Mol Cell Proteomics; 2013 Nov; 12(11):3285-96. PubMed ID: 23946468
[TBL] [Abstract][Full Text] [Related]
14. The thioredoxin antioxidant system.
Lu J; Holmgren A
Free Radic Biol Med; 2014 Jan; 66():75-87. PubMed ID: 23899494
[TBL] [Abstract][Full Text] [Related]
15. Dual pharmacological inhibition of glutathione and thioredoxin systems synergizes to kill colorectal carcinoma stem cells.
Tanaka G; Inoue K; Shimizu T; Akimoto K; Kubota K
Cancer Med; 2016 Sep; 5(9):2544-57. PubMed ID: 27485632
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of Thioredoxin/Thioredoxin Reductase Induces Synthetic Lethality in Lung Cancers with Compromised Glutathione Homeostasis.
Yan X; Zhang X; Wang L; Zhang R; Pu X; Wu S; Li L; Tong P; Wang J; Meng QH; Jensen VB; Girard L; Minna JD; Roth JA; Swisher SG; Heymach JV; Fang B
Cancer Res; 2019 Jan; 79(1):125-132. PubMed ID: 30401714
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of glutathione synthesis eliminates the adaptive response of ascitic hepatoma 22 cells to nedaplatin that targets thioredoxin reductase.
Wang Y; Lu H; Wang D; Li S; Sun K; Wan X; Taylor EW; Zhang J
Toxicol Appl Pharmacol; 2012 Dec; 265(3):342-50. PubMed ID: 22982619
[TBL] [Abstract][Full Text] [Related]
18. Cisplatin combined with zidovudine enhances cytotoxicity and oxidative stress in human head and neck cancer cells via a thiol-dependent mechanism.
Mattson DM; Ahmad IM; Dayal D; Parsons AD; Aykin-Burns N; Li L; Orcutt KP; Spitz DR; Dornfeld KJ; Simons AL
Free Radic Biol Med; 2009 Jan; 46(2):232-7. PubMed ID: 18983911
[TBL] [Abstract][Full Text] [Related]
19. Glutaminase Inhibitors Induce Thiol-Mediated Oxidative Stress and Radiosensitization in Treatment-Resistant Cervical Cancers.
Rashmi R; Jayachandran K; Zhang J; Menon V; Muhammad N; Zahner M; Ruiz F; Zhang S; Cho K; Wang Y; Huang X; Huang Y; McCormick ML; Rogers BE; Spitz DR; Patti GJ; Schwarz JK
Mol Cancer Ther; 2020 Dec; 19(12):2465-2475. PubMed ID: 33087507
[TBL] [Abstract][Full Text] [Related]
20. Radioresistant Cervical Cancers Are Sensitive to Inhibition of Glycolysis and Redox Metabolism.
Rashmi R; Huang X; Floberg JM; Elhammali AE; McCormick ML; Patti GJ; Spitz DR; Schwarz JK
Cancer Res; 2018 Mar; 78(6):1392-1403. PubMed ID: 29339540
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
